- Language: English
- 238 Pages
- Published: December 2011
- Region: Global
Epidemiology: Colorectal Cancer - Lifestyle risk factors and population dynamics drive incident cases
- Published: October 2011
- 51 pages
Over the past 3 decades, the incidence of colorectal cancer has increased in low incidence countries but stabilized in high incidence countries. However, in the seen major markets, aging populations, rising physical inactivity, and overweight ensure growth in colorectal cancer patient populations. Indeed, between 2010 and 2020, both incident and prevalent cases will increase.
Features and benefits
- Gain insights into the estimates and forecast of incident colon and rectal cancer cases in the US, Japan, France, Germany, Italy, Spain, and the UK.
- Understand the stage distribution of newly diagnosed colorectal cancer in these markets.
- Gain insights into the possible underlying risk factors driving the epidemiology of colorectal cancer in the seven major markets.
- In 2010, there were 375,400 people diagnosed with colon cancer in the seven major markets. Colon cancer diagnoses will increase by 21.6% to 456,500 in 2020. In 2010, the US, the five major EU markets, and Japan had 125,900, 81,200, and 168,300 incident cases, respectively.
- In 2010, there were 182,700 people diagnosed with rectal cancer in the seven major markets. Rectal cancer diagnoses will increase by 17% to 213,400 in 2020. In 2010, the US, the five major EU markets, and Japan had 54,700, 89,000, and 38,900 incident cases, respectively.
- Datamonitor estimates that prevalent cases of colon and rectal cancer will continue to increase in the seven major markets. In 2010, there were approximately 1.3 million and 598,900 prevalent cases of colon and rectal cancer cases, respectively. By the end of 2020, there will be about 1.58 million prevalent colon and 743,700 rectal cancer cases.
Your key questions answered
- What are the most robust sources for colorectal cancer incidence data?
- What is the current patient population of colorectal cancer in the seven major markets?
- How will the colorectal cancer patient population change over the next decade in the US, Japan, France, Germany, Italy, Spain, and the UK?
- How do changes in the population structure and the risk factors affect the trends in incident colorectal cancer cases? SHOW LESS READ MORE >
Disease burden overview
Colon cancer: incident cases will increase across the seven major markets
Rectal cancer: favorable survival accounts for high prevalent cases
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Classifying colorectal cancer
GLOBAL VARIATION AND HISTORICAL TRENDS
Incidence rates: stabilizing incidence rates reported in seven major markets
Prevalence: improvements in survival leading to increase in prevalent cases
Physical activity and body mass index
Vegetables and fruit
Other dietary factors
Low proportion of colorectal cancers due to genetic susceptibility
Non-steroidal anti-inflammatory drugs
EPIDEMIOLOGIC FORECASTING OF COLORECTAL CANCER
Cancer registries: age- and sex-specific incidence rates
Description of methods
Estimated incident cases of colon cancer: substantial increase in new diagnoses
Age-adjusted incidence rate of colon cancer: rapid increases in Spain and Germany
Segmentation of incident colon cases in
Estimated prevalent cases of colon cancer: favorable survival increases prevalent cases
Estimated incident cases of rectal cancer: lifestyle and demographic factors increase incidence
Age-adjusted incidence rate of rectal cancer: constant rates across markets
Segmentation of incident rectal cases in
Estimated prevalent cases of rectal cancer
Growth in screening coverage reduces incidence of colorectal cancer
Aging population and lifestyle factors drive incidence
Differences in distribution of risk factors and screening coverage lead to variations in incidence across the block